P W Mason - JoVE Visualize

Showing results (71-80 of 80) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 80 results.

Virus Research|August 26, 1998

Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virusM R Almeida, E Rieder, J Chinsangaram, et al.

Virology|March 1, 1992

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitisS Pincus, P W Mason, E Konishi, et al.

Journal of Virology|April 29, 1998

Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptorS Neff, D Sá-Carvalho, E Rieder, et al.

Virology|June 1, 1987

Partial nucleotide sequence of the Japanese encephalitis virus genomeP C McAda, P W Mason, C S Schmaljohn, et al.

Journal of Biomedical Engineering|April 1, 1984

A miniature infuser for the pulsatile administration of LHRHI A Sutherland, S White, G R Chambers, et al.

The Veterinary Record|August 26, 2003

Procedures for preventing the transmission of foot-and-mouth disease virus to pigs and sheep by personnel in contact with infected pigsS F Amass, J M Pacheco, P W Mason, et al.

BMJ (Clinical Research Ed.)|March 25, 1989

One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulationR Homburg, A Eshel, N A Armar, et al.

Vaccine|June 17, 1998

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidatesE Konishi, I Kurane, P W Mason, et al.

The Journal of General Virology|August 1, 1989

Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoproteinP W Mason, J M Dalrymple, M K Gentry, et al.

Vaccine|October 12, 2000

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humansN Kanesa-thasan, J J Smucny, C H Hoke, et al.

Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 80 results.

Virus Research|August 26, 1998

Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virusM R Almeida, E Rieder, J Chinsangaram, et al.

Virology|March 1, 1992

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitisS Pincus, P W Mason, E Konishi, et al.

Journal of Virology|April 29, 1998

Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptorS Neff, D Sá-Carvalho, E Rieder, et al.

Virology|June 1, 1987

Partial nucleotide sequence of the Japanese encephalitis virus genomeP C McAda, P W Mason, C S Schmaljohn, et al.

Journal of Biomedical Engineering|April 1, 1984

A miniature infuser for the pulsatile administration of LHRHI A Sutherland, S White, G R Chambers, et al.

The Veterinary Record|August 26, 2003

Procedures for preventing the transmission of foot-and-mouth disease virus to pigs and sheep by personnel in contact with infected pigsS F Amass, J M Pacheco, P W Mason, et al.

BMJ (Clinical Research Ed.)|March 25, 1989

One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulationR Homburg, A Eshel, N A Armar, et al.

Vaccine|June 17, 1998

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidatesE Konishi, I Kurane, P W Mason, et al.

The Journal of General Virology|August 1, 1989

Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoproteinP W Mason, J M Dalrymple, M K Gentry, et al.

Vaccine|October 12, 2000

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humansN Kanesa-thasan, J J Smucny, C H Hoke, et al.

Pageof 8